Every tracked price, with its source and the date we checked it. Rows confirmed on the provider’s own live site are marked primary; rows from secondary comparison data are marked not independently re-verified. Sorted low to high.
Advertised price · last checked · availability may vary by state and prescribing basis. Providers’ own figures for compounded product, which is not FDA-approved. Listing is not endorsement.
| Provider | Monthly | Prepaid effective | Membership | Shipping | Dose-increase | Source | Last checked | Provenance |
|---|---|---|---|---|---|---|---|---|
| Fifty 410 | from $133 | prepaid/tiered | None stated | Free (stated) | Rises with dose | fifty410.com | 2026-06-25 | primary |
| Henry Meds | $179 | — | None stated | Included (stated) | Flat (stated) | Secondary comparison data | 2026-06 | not re-verified |
| NexLife | $215 | $186 (12-mo) | None (stated) | Free expedited (stated) | Same at every dose (stated) | nexlife.us | 2026-06-25 | primary |
| Mochi Health | ~$278 eff. | — | ~$79 base | Verify | Verify per dose | Secondary comparison data | 2026-06 | not re-verified |
Provenance key. primary = confirmed on the provider’s live page on the date shown. not re-verified = from secondary sources, treat as indicative. NexLife note: its own pages list tirzepatide at both $186 and $215 depending on plan length.